Bayer Aktiengesellscha (Germany) Performance
| BAYA Stock | EUR 4.94 0.24 5.11% |
The firm shows a Beta (market volatility) of 0.36, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bayer Aktiengesellscha's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bayer Aktiengesellscha is expected to be smaller as well. At this point, Bayer Aktiengesellschaft has a negative expected return of -0.38%. Please make sure to confirm Bayer Aktiengesellscha's kurtosis, daily balance of power, and the relationship between the skewness and accumulation distribution , to decide if Bayer Aktiengesellschaft performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Bayer Aktiengesellschaft has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
| Begin Period Cash Flow | 4.2 B | |
| Total Cashflows From Investing Activities | 855 M |
Bayer |
Bayer Aktiengesellscha Relative Risk vs. Return Landscape
If you would invest 670.00 in Bayer Aktiengesellschaft on August 25, 2024 and sell it today you would lose (176.00) from holding Bayer Aktiengesellschaft or give up 26.27% of portfolio value over 90 days. Bayer Aktiengesellschaft is producing return of less than zero assuming 4.0478% volatility of returns over the 90 days investment horizon. Simply put, 36% of all stocks have less volatile historical return distribution than Bayer Aktiengesellscha, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bayer Aktiengesellscha Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bayer Aktiengesellscha's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bayer Aktiengesellschaft, and traders can use it to determine the average amount a Bayer Aktiengesellscha's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0938
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | BAYA |
Estimated Market Risk
| 4.05 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.38 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.09 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Bayer Aktiengesellscha is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bayer Aktiengesellscha by adding Bayer Aktiengesellscha to a well-diversified portfolio.
Bayer Aktiengesellscha Fundamentals Growth
Bayer Stock prices reflect investors' perceptions of the future prospects and financial health of Bayer Aktiengesellscha, and Bayer Aktiengesellscha fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bayer Stock performance.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0576 | |||
| Current Valuation | 82.93 B | |||
| Shares Outstanding | 3.93 B | |||
| Price To Earning | 12.22 X | |||
| Price To Book | 1.32 X | |||
| Price To Sales | 1.00 X | |||
| Revenue | 44.08 B | |||
| EBITDA | 6.45 B | |||
| Cash And Equivalents | 8.19 B | |||
| Cash Per Share | 2.09 X | |||
| Total Debt | 35.55 B | |||
| Debt To Equity | 1.13 % | |||
| Book Value Per Share | 10.50 X | |||
| Cash Flow From Operations | 5.09 B | |||
| Earnings Per Share | 1.17 X | |||
| Total Asset | 120.24 B | |||
About Bayer Aktiengesellscha Performance
By analyzing Bayer Aktiengesellscha's fundamental ratios, stakeholders can gain valuable insights into Bayer Aktiengesellscha's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bayer Aktiengesellscha has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bayer Aktiengesellscha has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. BAYER ADR is traded on Frankfurt Stock Exchange in Germany.Things to note about Bayer Aktiengesellschaft performance evaluation
Checking the ongoing alerts about Bayer Aktiengesellscha for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bayer Aktiengesellschaft help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bayer Aktiengesellscha generated a negative expected return over the last 90 days | |
| Bayer Aktiengesellscha has high historical volatility and very poor performance |
- Analyzing Bayer Aktiengesellscha's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bayer Aktiengesellscha's stock is overvalued or undervalued compared to its peers.
- Examining Bayer Aktiengesellscha's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bayer Aktiengesellscha's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bayer Aktiengesellscha's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bayer Aktiengesellscha's stock. These opinions can provide insight into Bayer Aktiengesellscha's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bayer Stock analysis
When running Bayer Aktiengesellscha's price analysis, check to measure Bayer Aktiengesellscha's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bayer Aktiengesellscha is operating at the current time. Most of Bayer Aktiengesellscha's value examination focuses on studying past and present price action to predict the probability of Bayer Aktiengesellscha's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bayer Aktiengesellscha's price. Additionally, you may evaluate how the addition of Bayer Aktiengesellscha to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |